idarubicin has been researched along with Pregnancy in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 8 (40.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Abe, Y; Ishida, T; Kasai, Y; Kasuya, Y; Kikuchi, T; Nomura, M; Norihama, Y; Oda, Y; Ogura, M; Sato, K; Takei, T; Tsukada, N | 1 |
Chan, SY; Dang, CC; Guan, YK; Lau, NS | 1 |
Emoto, I; Kanbayashi, S; Kim, T; Maruyama, S; Moriuchi, K; Ri, Y; Sato, Y; Taga, A | 1 |
Arnold, AJ; Gilmour, GS; Koch, MW | 1 |
Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K | 1 |
Casale, MF; de Lisa, E; Díaz-Mediavilla, J; Fernández, I; Fernández, P; González, JD; González-Campos, J; Herrera, P; Jiménez, S; Montesinos, P; Olave, T; Pellicer, A; Perales, A; Rojas, R; Salamero, O; Sanz, MA; Sayas, MJ | 1 |
Choi, JR; Han, JH; Kim, JK; Kim, JS; Kim, SJ; Lee, EY; Lee, HJ; Lee, KA; Lee, ST; Park, TS; Seok, YM; Song, J | 1 |
Driul, L; Fachechi, G; Ganzitti, L; Marchesoni, D | 1 |
Akiyama, N; Ayabe, T; Kawasugi, K; Nishi, R; Oka, Y; Shirafuji, N; Shirasaki, R; Shirota, M; Taguchi, A; Tashiro, H; Umezawa, K | 1 |
Aoki, A; Miyazono, T; Saito, S; Sugiyama, T; Yoneda, N; Yoneda, S | 1 |
Asea, A; Boos, J; Borkhardt, A; Dantonello, T; Hoehn, T; Klee, D; Koscielniak, E; Krefeld, B; Siepermann, M; Wessalowski, R | 1 |
Austin, N; Bayston, K; Carradice, D; Ganly, PS | 1 |
Consoli, U; Figuera, A; Giustolisi, R; Guido, G; Indelicato, F; Leotta, S; Meli, CR; Milone, G; Moschetti, G; Murgano, P; Pinto, V; Poidomani, M; Tornello, A | 1 |
Akercan, F; Cagirgan, S; Donmez, A; Mgoyi, L; Ozkinay, E; Vural, F; Yucebilgin, MS | 1 |
Gentilini, O; Goldhirsch, A; Martinelli, G; Peccatori, F | 1 |
Koyama, M; Matsuo, K; Murata, Y; Shimoya, K; Ueda, S; Wada, K | 1 |
Huerta, F; Reynoso, EE | 1 |
Claahsen, HL; Mattijssen, V; Semmekrot, BA; van Dongen, PW | 1 |
Achtari, C; Hohlfeld, P | 1 |
Alimena, G; Breccia, M; Cimino, G; De Carolis, S; Lo Coco, F; Mandelli, F | 1 |
4 review(s) available for idarubicin and Pregnancy
Article | Year |
---|---|
[Acute myelogenous leukemia developed at the 26th week of gestation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cytarabine; Female; Humans; Idarubicin; Infant, Low Birth Weight; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, Second; Remission Induction | 2011 |
Acute promyelocytic leukemia during pregnancy: report of 3 cases.
Topics: Abnormalities, Drug-Induced; Abortion, Therapeutic; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Case Management; Cesarean Section; Fatal Outcome; Female; Gestational Age; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Risk; Safety; Tretinoin | 2004 |
Acute myeloblastic leukemia in pregnancy: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Drug Administration Schedule; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Third | 2004 |
AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cytarabine; Disseminated Intravascular Coagulation; Female; Gestational Age; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Neoplastic; Remission Induction; Risk; Tretinoin | 2002 |
16 other study(ies) available for idarubicin and Pregnancy
Article | Year |
---|---|
[Acute myeloid leukemia with t (8;21) translocation diagnosed at 21 weeks of gestation resulting in full-term delivery without chemotherapy].
Topics: Adult; Cesarean Section; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Pregnancy; Translocation, Genetic | 2023 |
Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Pregnancy; Recurrence; Tretinoin; Young Adult | 2020 |
Fetal death following idarubicin treatment for acute promyelocytic leukemia in pregnancy-A case report.
Topics: Adult; Antibiotics, Antineoplastic; Female; Fetal Death; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic | 2017 |
Clinical Reasoning: A pregnant woman with chin numbness.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Chin; Consolidation Chemotherapy; Cytarabine; Emergency Service, Hospital; Fatigue; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypesthesia; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Meningeal Carcinomatosis; Paresthesia; Pregnancy; Pregnancy Complications, Neoplastic; Spinal Puncture; Sweating; Upper Extremity | 2019 |
Myeloma presenting during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous | 2014 |
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Databases, Factual; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Remission Induction; Tretinoin; Young Adult | 2015 |
Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Female; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Karyotyping; Korea; Leukemia, Promyelocytic, Acute; Nuclear Proteins; Oncogene Proteins, Fusion; Pregnancy; Pregnancy Complications, Neoplastic; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Translocation, Genetic; Tretinoin; Tumor Suppressor Proteins | 2009 |
Acute promyelocytic leukemia during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Fetal Monitoring; Humans; Idarubicin; Infant, Newborn; Interdisciplinary Communication; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Tretinoin | 2010 |
Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Neoplastic; Tretinoin | 2011 |
Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Rhabdomyosarcoma, Alveolar | 2012 |
Successful treatment of acute promyelocytic leukaemia during pregnancy.
Topics: Adolescent; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cesarean Section; Dexamethasone; Diuretics; Epilepsy, Tonic-Clonic; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Lung; Neutropenia; Nutrition Disorders; Oxygen; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Remission Induction; Respiration Disorders; Tranexamic Acid; Tretinoin | 2002 |
Chemotherapy during pregnancy: what is really safe?
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Fetal Diseases; Humans; Idarubicin; Maternal Exposure; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome | 2004 |
Idarubicin administered during pregnancy: its effects on the fetus.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Drug Therapy, Combination; Female; Fetus; Gestational Age; Heart Rate, Fetal; Humans; Idarubicin; Leukemia, Myeloid, Acute; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Shock, Septic; Treatment Outcome | 2004 |
Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Death; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Remission Induction | 1994 |
Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Infant, Premature; Leukemia, Monocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prenatal Exposure Delayed Effects | 1998 |
Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy.
Topics: Adult; Antibiotics, Antineoplastic; Female; Heart; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Placenta; Pregnancy; Pregnancy Trimester, Second | 2000 |